BROSSARD, QUEBEC — (Marketwired) — 09/26/17 — DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, is pleased to announce that the Corporation–s common shares traded on the OTC Markets Group Inc.–s OTCQB Venture Market in the United States, under the symbol "DGNOF", are Depository Trust Company ("DTC") eligible, effective Sept
Finished Intelligence, Deep & Dark Web, and Risk Intelligence Observables Datasets Help Customers Mitigate Risk and Empower Partners to Create Custom Integrations